Ameritas Investment Partners’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.1K Hold
2,936
﹤0.01% 2635
2025
Q4
$30.6K Sell
2,936
-700
-19% -$7.02K ﹤0.01% 2426
2025
Q3
$32.7K Hold
3,636
﹤0.01% 2440
2025
Q2
$47.3K Hold
3,636
﹤0.01% 2221
2025
Q1
$91.8K Hold
3,636
﹤0.01% 1765
2024
Q4
$125K Hold
3,636
﹤0.01% 1631
2024
Q3
$180K Buy
3,636
+303
+9% +$15.5K 0.01% 1393
2024
Q2
$201K Buy
3,333
+390
+13% +$22.3K 0.01% 1264
2024
Q1
$152K Hold
2,943
0.01% 1480
2023
Q4
$119K Buy
2,943
+271
+10% +$7.95K ﹤0.01% 1621
2023
Q3
$74.5K Buy
2,672
+434
+19% +$12.9K ﹤0.01% 1856
2023
Q2
$64.5K Buy
2,238
+331
+17% +$7.36K ﹤0.01% 1885
2023
Q1
$31.8K Buy
1,907
+537
+39% +$7.58K ﹤0.01% 2234
2022
Q4
$17.8K Hold
1,370
﹤0.01% 2608
2022
Q3
$16K Hold
1,370
﹤0.01% 2629
2022
Q2
$19K Hold
1,370
﹤0.01% 2572
2022
Q1
$17K Buy
1,370
+730
+114% +$8.76K ﹤0.01% 2626
2021
Q4
$7K Hold
640
﹤0.01% 2992
2021
Q3
$8K Buy
+640
New +$8.81K ﹤0.01% 2994

Other funds holding RXST

Ameritas Investment Partners's RXST Position: Q1 2026 in Review

Ameritas Investment Partners held its RxSight (RXST) position steady in Q1 2026 at 2,936 shares worth $18.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2635.

Ameritas Investment Partners first reported a position in RXST in Q3 2021 and has held it in 19 quarters since. The position peaked at $201K in Q2 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Ameritas Investment Partners held 2,936 shares of RxSight worth $18.1K as of Q1 2026.
  • Ameritas Investment Partners left its RxSight share count unchanged in Q1 2026.
  • RxSight made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2635 holding.
  • Ameritas Investment Partners first reported a position in RxSight in Q3 2021 and has held it in 19 quarters since.
  • Ameritas Investment Partners's RxSight position peaked at $201K in Q2 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.